Meeder Asset Management’s Bio-Path Holdings Inc BPTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11
Closed -$3K 1841
2018
Q3
$3K Buy
11
+4
+57% +$2.16K ﹤0.01% 1417
2018
Q2
$4.07K Buy
7
+2
+40% +$1.39K ﹤0.01% 1311
2018
Q1
$4K Buy
5
+3
+150% +$2.34K ﹤0.01% 1296
2017
Q4
$1K Hold
2
﹤0.01% 1610
2017
Q3
$2K Buy
2
+1
+100% +$1.37K ﹤0.01% 1492
2017
Q2
$1K Hold
1
﹤0.01% 1570
2017
Q1
$3K Hold
1
﹤0.01% 1292
2016
Q4
$5K Buy
+1
New +$4.84K ﹤0.01% 863

Other funds holding BPTH

Meeder Asset Management's BPTH Position: Q4 2018 in Review

Meeder Asset Management sold out of Bio-Path Holdings Inc (BPTH) in Q4 2018, closing a stake of 11 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in BPTH in Q4 2016 and held it in 8 quarters. The position peaked at $5K in Q4 2016. 17 funds tracked by Wall St. Rank hold BPTH as of Q4 2018.

  • Meeder Asset Management reported no remaining Bio-Path Holdings Inc position as of Q4 2018 after selling out during the quarter.
  • Meeder Asset Management sold 11 Bio-Path Holdings Inc shares in Q4 2018, an estimated $3K.
  • Meeder Asset Management first reported a position in Bio-Path Holdings Inc in Q4 2016 and held it in 8 quarters.
  • Meeder Asset Management's Bio-Path Holdings Inc position peaked at $5K in Q4 2016.
  • 17 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2018.

Based on Meeder Asset Management's 13F filing for Q4 2018, filed 17 Jan 2019.